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Background: Mutations in the EXT genes disrupt polymerisation of heparan sulphates (HS) and lead to the
development of osteochondroma, an isolated/sporadic- or a multifocal/hereditary cartilaginous bone tumour.
Zebrafish (Danio rerio) is a very powerful animal model which has shown to present the same cartilage phenotype
that is commonly seen in mice model and patients with the rare hereditary syndrome, Multiple Osteochondroma
(MO).
Methods: Zebrafish dackel (dak) mutant that carries a nonsense mutation in the ext2 gene was used in this study. A
panel of molecular, morphological and biochemical analyses was used to assess at what step bone formation is
affected and what mechanisms underlie changes in the bone formation in the ext2 mutant.
Results: During bone development in the ext2−/− zebrafish, chondrocytes fail to undergo terminal differentiation;
and pre-osteoblasts do not differentiate toward osteoblasts. This inadequate osteogenesis coincides with increased
deposition of lipids/fats along/in the vessels and premature adipocyte differentiation as shown by biochemical and
molecular markers. Also, the ext2-null fish have a muscle phenotype, i.e. muscles are shorter and thicker. These
changes coexist with misshapen bones. Normal expression of runx2 together with impaired expression of osterix
and its master regulator - xbp1 suggest that unfolded protein responses might play a role in MO pathogenesis.
Conclusions: Heparan sulphates are required for terminal differentiation of the cartilaginous template and
consecutive formation of a scaffold that is needed for further bone development. HS are also needed for
mesenchymal cell differentiation. At least one copy of ext2 is needed to maintain the balance between bone and
fat lineages, but homozygous loss of the ext2 function leads to an imbalance between cartilage, bone and fat
lineages. Normal expression of runx2 and impaired expression of osterix in the ext2−/− fish indicate that HS are
required by osteoblast precursors for their further differentiation towards osteoblastic lineage. Lower expression of
xbp1, a master regulator of osterix, suggests that HS affect the ‘unfolded protein response’, a pathway that is known
to control bone formation and lipid metabolism. Our observations in the ext2-null fish might explain the
musculoskeletal defects that are often observed in MO patients.
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Figure 1 Manifestations of multiple osteochondromas (MO) in
a patient. A, Photograph of a 7-year-old patient with MO demonstrates
marked forearm deformities. B, In his radiograph, the most common type
of deformity is seen: a combination of relative shortening of the ulna,
bowing of the radius and ulna, increased ulnar tilt of the distal radial
epiphysis, and ulnar deviation of the hand (Courtesy of Mikel San Julian,
MD, Department of Orthopaedic Surgery and Traumatology, University
Clinic of Navarra, Pamplona, Spain).
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Bone formation and homeostasis are complex processes
in which many cell types and various signalling pathways
are involved. Chondrocytes and osteoblasts originate
from the same precursors - mesenchymal stem cells,
which can also differentiate towards adipocytes, fibro-
blasts, myoblasts and epithelial cells. The osteoblast
lineage is under strict control of RUNT-RELATED
TRANSCRIPTION FACTOR 2 (RUNX2) and its down-
stream target - SP7/OSTERIX, which can work in a
Runx-dependent and/or an independent manner. Runx2
and Osterix mRNA are expressed in the immature chon-
dro/osteoprogenitor cells and osteoblasts only [1] and al-
terations in the expression of either of the two genes
affect bone development. Runx- and Osterix-null mice
have normal cartilage but their reduced or absent ex-
pression of type I collagen, bone sialoprotein, osteonec-
tin, osteopontin, and osteocalcin indicate that bone
development is blocked at the step of pre-osteoblast to
osteoblast differentiation [2]. Mammalian cells treated
with an Osterix inhibitor, dexamethasone, enter an
adipogenic- instead of osteoblastic lineage [3]. This im-
balance between bone and fat is a known phenomenon.
For example, it has been shown that knockout mice,
which are heterozygous for Peroxisome proliferator-
activated receptor γ (PPARγ have impaired adipogenesis,
coinciding with an increased osteoblast number [4].
Other signalling molecules such as wingless (Wnt), bone
morphogenic protein (BMP), and hedgehog were also
shown to trigger the switch between different lineages
including a bone-to-fat change. Remarkably, in all of
these pathways, receptor-ligand binding and gradient
formation is dependent on heparan sulphates (HS).
Heparan sulphate (HS) are glycosaminoglycans, heavily
sulphated linear polysaccharides, that are present in all
type of cells. Once they become attached to a core pro-
tein they form proteoglycans. The biosynthesis of HS
take place in the Golgi apparatus and endoplasmic
reticulum, where the elongation of glycosaminoglycan
chains is maintained by type II glycosyltransferases
encoded by the EXOSTOSINs genes, EXT1 and EXT2
[5]. Several genes are involved in the biosynthesis and
degradation of HS, and mutations affecting the HS pro-
duction have serious consequences. Abnormal accumu-
lation of HS, due to its impaired degradation, causes
mucopolysaccharidosis, a progressive disorder affecting
mental and physical abilities, causing damage to various
organs and leading to premature death. Patients with
mucopolysaccharidosis often display skeletal abnormal-
ities such as short stature or abnormal bone density
[6,7]. Decreased levels of HS due to mutations in EXT1
or EXT2 also lead to a skeletal abnormality resulting in
one of the most common benign bone tumours in young
adults – osteochondroma [8]. The hereditary form ofosteochondroma, multiple osteochondromas (MO; pre-
viously named multiple hereditary exostosis, MHE or
hereditary multiple exostosis, HME), is a syndrome that
is characterized by the development of multiple tumours
(osteochondromas) at different sites of the endochondral
skeleton [9]. MO is also associated with various other
skeletal and non-skeletal phenotypes such as short stat-
ure, bone bowing (Figure 1), impingement of tendons,
muscles or nerves as well as low bone density, lipid de-
position within osteochondromas, pain and scarring
[9-13].
Several mice models have been developed to study the
role of EXT1 or EXT2 in bone and osteochondroma for-
mation [14]. Zebrafish (Danio rerio) have also been
shown to be a powerful animal model with morpho-
logical and developmental pathways comparable to those
seen in humans [15]. We use zebrafish dackel (dak) mu-
tants that carry a nonsense mutation in the ext2, gene
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EXT2 [16]. The ext2−/− fish have been used as a model
for MO. They have shown to mimic the cartilage pheno-
type (organization and behaviour) that is common to all
models and the dental phenotype present in a number
of patients but never described in mice [17-20].
In this study we show that bone development in the
zebrafish ext2−/− mutant is affected at two levels/stages
in osteogenesis. Firstly development of the scaffold that
is needed for osteoblasts to generate the bone is de-
layed/absent because chondrocytes fail to undergo ter-
minal differentiation. Secondly, bone formation fails to
progress from pre-osteoblasts towards osteoblasts and
this change coexists with abnormal lipid depositions and
premature adipocyte differentiation. Compounds stimu-
lating fat-to-bone shift, GW9662 and purmorphamine,
stimulate bone development in WT and ext2 heterozy-
gote but do not rescue the ext2-null bones. Reduced ex-
pression of xbp1, the master regulator of osterix,
suggests that unfolded protein responses might play an
important role in MO pathogenesis. Beside the “low
bone-high fat phenotype”, the ext2-null fish also have a
muscle phenotype, i.e. muscles are shorter and thicker,
and therefore might have different mechanical proper-
ties. Bone bowing, weak muscles and muscle fatigue are
often observed in MO patients. Based on our findings in
the fish model we speculate that bone bowing may occur
as a result of weaker “fat bones” being distorted by mus-
cles (with different mechanical properties). In support of
this concept misshaped clavicles and bowed Meckel’s are
a very frequent phenomenon in the ext2-null mutant
fish (data not shown).
Materials and methods
Animals
All experiments on zebrafish were performed in accord-
ance with national and institutional guidelines for the care
and use of laboratory animals. Zebrafish (Danio rerio H.)
AB, golden and albino strains were used as wild type (WT)
lines. Homozygote dackel (dak, ext2to273b), knypek (kny,
gpcu34.8), pinscher (pic, slc35b214MX), hi307 ( β 3gat3hi307)
and hi954 (uxs1hi954) mutants were obtained in natural
crosses and staged according to Kimmel et al. [21]. The
dak mutant was also kept in a Tg(osteix:GFP) background
[22]. Unless stated otherwise, embryos were anaesthetized
in tricane, fixed in 4% paraformaldehyde, dehydrated in a
series of methanol dilutions and stored at −20°C.
Bones were stained with Alizarin red as described pre-
viously [17]. Lipid deposits were visualized with Oil red
O as described by Li and co-authors [23].
Drug treatment
Groups of 50 eggs were placed in a Petri dish with 20 ml
E3 medium. Prior to treatment fish larvae were manuallydecorionated. GW9662 (Sigma) at concentration of 5-
20 μM and/or purmorphamine (Calbiochem) at concen-
trations of 2,5-20 μM were added at 48, 60, 72, and
96 hours post fertilization (hpf ) directly into E3 in which
larvae were grown. 2-40 μM SB431542 (Tocris Bio-
trend), 0.2-4 μM dorsomorphin, 1-10 ng/ml TGF-β3
(Oncogene Sci.), or 10-2500 ng/ml BMP6 (a gift from
Dr. K. Sampath, Curis, Cambridge, MA) were added into
E3 from 48 hpf. For control, equal volume of DMSO
(solvent) was added. In case of TGF-β3 and BMP6 acti-
vators, as a solvent and control, 4 mM HCl and 0.1%
BSA were used. At 6 days post fertilization (dpf) fish
were analysed for osterix expression (fish with transgenic
osterix:GPP in the background) and for bone calcifica-
tion (Alizarin red).
In situ hybridization and immunohistochemistry
Whole mount mRNA in situ was done accordingly to
Thiesse 2008 [24] using: fabp11a, fabp11b and pparg
rybo-probes. For amplification of the probe templates fol-
lowing primers were used: fabp11a_F 5′-GATCAAATC
TCAATTTACAGCTGTTG-3′, fabp11a_R + T7 5′-TAAT
ACGACTCACTATAGGGTTCAAAGCACCATAAAGAC
TGATAAT-3′, fabp11b_F 5′-AACACTTTGTGCTATT
ATCTGTC-3′, fabp11b_R + T7 5′-TAATACGACTCACT
ATAGGGCCATCCGCAAGGCTCATAG-3′, pparg_F2
5′-TGCAGAGAACAGCGTTTCAT-3′ and pparg_R1 +
T7 5′-TAATACGACTCACTATAGGGCACTTCGATGA
CCCCGTACT-3′. Whole mount immunostaining on zeb-
rafish embryos was performed as described previously [17]
using as a primary antibodies from the Developmental
Studies Hybridoma Bank: anti-MF-20 for muscles and col-
lagen II for cartilage, both in dilution of 1:250. For light
microscopy, the anti-Digoxigenin-AP, Fab fragments
(Roche) at 1:4000 or anti-mouse AP (Sigma) at 1:500
followed by BCIP/NBT (Sigma) were used to detect the
signal. For confocal microscopy, Alexa 488 and 546 were
used as the secondary antibody in dilution 1:200. Each ex-
periment was repeated at least three times. Morphological
evaluation was then performed by comparing of the ext2
homozygote mutant with its normal counterpart.
Quantitative RT-PCR
The expression levels of bone-, cartilage- and adipocyte-
specific markers were determined by quantitative real
time PCR. RNA extraction was performed as described
by de Jong and colleagues with on-column DNase I
digestion [25]. cDNA synthesis was performed as de-
scribed previously [26]. Possible genomic contamination
in the cDNA preparations was tested by PCR using
col1a2 primers and confirmed as negative. The primer
sets were designed using Primer3 online program. The
sequences of the qPCR primers are listed in Table 1. Un-
less stated otherwise, the primers were designed as such
Table 1 Sequences of primers used for quantitative PCR
Primer name Sequence 5′→ 3′ Lineage Gene structure
adopql qPCR F1 AACCTGGAAGAGATGGCAGA A
adopql qPCR R1 CAGGAAAGCCTCTTGGTCCT A
cebpa qPCR F1 CACAACAGCTCCAAGCAAGA A #
cebpa qPCR R1 AATCCATGTAGCCGTTCAGG A #
cebpb qPCR F1 TGTTCAGCCCGGACTTTATG A #
cebpb qPCR R1 AGTCTGGTACGGCAGGTACG A #
col1a2 qPCR F2 CTGGCATGAAGGGACACAG B
col1a2 qPCR R2 GGGGTTCCATTTGATCCAG B
col10a1 qPCR F2 CCTGTCTGGCTCATACCACA C
col10a1 qPCR R2 AAGGCCACCAGGAGAAGAAG C
osteocalcin qPCR F1 TGAGTGCTGCAGAATCTCCTAA B
osteocalcin qPCR R1 GTCAGGTCTCCAGGTGCAGT B
osteopontin qPCR F1 TGAAACAGATGAGAAGGAAGAGG B
osteopontin qPCR R1 GGGTAGCCCAAACTGTCTCC B
osterix qPCR F2 GCGTCGATTCTGGAGGAG B
osterix qPCR R2 AATCTCGGACTGGACTGGTG B
pparg qPCR F1 GGTTTCATTACGGCGTTCAC A
pparg qPCR R1 TGCGGCTCTTCTTGTGTATG A
runx2a qPCR F1 AACTTTCTGTGCTCGGTGCT B, C
runx2a qPCR R1 GTCATTTCCAGCCATTACCG B, C
runx2b qPCR F2 CAAACACCCAGACCCTCACT B, C
runx2b qPCR R2 GTATGACCATGGTGGGGAAG B, C
scd1 qPCR F1 GTGGCGAAATGTCATTCTGA A
scd1 qPCR R1 CCATACACGAAACACGCAAA A
slc25a5 qPCR F1 CCCCCATTGAGAGAGTCAAA HK
slc25a5 qPCR R1 CCTCTCCAGAACGACAGGAA HK
sox9a qPCR F1 GGAGCTCAGCAAAACTCTGG C
sox9a qPCR R1 AGTCGGGGTGATCTTTCTTG C
srebp1c qPCR F1 CCCCCAGCAGACTCTCTACA A
srebp1c qPCR R1 CGACAGACTCTGGATCGTCA A
A, adipocyte-specific gene; B, bone specific gene; C, cartilage specific gene; HK, house keeping gene. #, gene with one exon.
Unless stated otherwise, the primers were designed to construct amplicons of 100–150 bp, spanning at least one intron to avoid amplification from possible
genomic DNA contaminant in the template.
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one intron. Tm was set at 60 ± 1°C. Quantitative real
time PCR was carried out in BioRad iCycler system
with SYBR Green SuperMix (BioRad), and was ana-
lysed with iCycler IQ (40 cycles, 1 min 95°C for
denaturation and 1 min 60°C for annealing and
elongation). All the samples were examined in dupli-
cate or triplicate, and the expression of each marker
was normalized to slc25a5 level. slc25a5 is one of a few
house-keeping genes which, accordingly to our array
data, is not differentially regulated in the ext2−/− fish
(unpublished).Lipid analysis
For Oil red O stain, 6 days old fish were anesthetized in
tricane and fixed in 4% paraformaldehyde for 1–3 hours
at room temperature prior to 10 minutes incubation
with the dye. After staining, fish were washed twice in
PBS and sorted by phenotype to homozygote mutant
and siblings. Oil red O was extracted from a group of
10 phenotyped fish by over-night incubation in 100%
methanol and quantified by measuring absorbance at
518 nm.
For TLC analysis, 6 days old fish were anaesthetized in
tricane, sorted in groups of 20 fish. WT, siblings or
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in a mixture of chloroform:methanol (2:1, v/v) and incu-
bated at room temperature for 15 minutes. To 1 ml of
extract 300 μl of water was added. Samples were quickly
vortexed at 2000 rpm for 5 minutes. Bottom phase was
washed twice with 0.5 ml of water to be finally reduced
in a speed-vacuum. Concentrated lipid extracts were
spotted on a Silica gel 60 TLC plate (Merck). Plates were
developed in a mixture of chloroform–ethanol–water–
triethylamine (30:35:7:35, v/v/v/v), sprayed with primu-
line and viewed under ultraviolet light.
Statistical analysis
Data are given as mean ± standard error of mean (SEM).
One sample t-test for comparing column means to a
hypothetical value or two samples unpaired Student’s
test for comparison of two groups were used to deter-
mine statistical significance and described as * for
p < 0.05, ** for p < 0.005 and *** for p < 0.001.
Results
Impaired bone development in the ext2−/− fish has been
described previously [17-19]. In order to identify at what
step bone formation is affected and what mechanisms
underlie changes in the ext2 mutant, we examined the ex-
pression of various bone molecular markers in the ext2−/−
fish and compared it with its siblings (Figure 2).
The importance of HS for pre-osteoblast differentiation
Our previous mRNA in situ analyses demonstrated nor-
mal expression patterns of collagen2, sox9a, and chon-
dromodulin in the ext2−/− fish, but did not give goodFigure 2 Bone development is impaired in the ext2−/− fish. A, Alizarin
bones: dentary (d), maxilla (mx), parasphenoid (p), endopterygoid (e), branc
hyomandibula (hm), ceratohyal (ch). ceratobranchial 5/pharyngeal arch (pa
expression of bone markers at 5dpf was evaluated by real time PCR and an
The results represent an average from minimum four single embryos. Expre
SEM. Expression of the ext2 was given as an example of a gene that was ap
biological relevance.estimates of the expression levels of these molecules
[17,18]. In this work, using real time PCR, we confirm
that in the homozygote ext2 mutants, the expression
levels of early skeletal markers such as runx2 are main-
tained at wild-type-levels whereas late skeletal markers
such as osterix, collagen1a1, osteopontin and osteocal-
cin are approximately 2-fold down-regulated and colla-
gen 10a1 shows even greater reduction (Figure 2B).
Gene expression data indicate that HS are needed by
chondrocytes for terminal differentiation for providing
a scaffold for developing bone, and for maintenance of
the osteochondroprogenitors/preosteoblasts to osteo-
blastic lineage.
Bone loss coincides with elevated lipid levels, premature
adipocyte differentiation and misshapen musculature in
the ext2−/− fish
Mesenchymal precursors can differentiate toward skeletal-
forming cells (osteoblasts and/or chondroblasts) and/or
other lineages such as myoblasts and adipocytes [27]. Al-
though differentiation of each lineage is controlled by
multiple factors including HS-dependent hedgehog, Wnt
or BMP, a switch in the fate of single or multiple lineages
can be trigged relatively easily. Thus, we assessed whether
diminished bone development in the ext2−/− fish is com-
pensated with gain of other lineage(s).
The whole mount MF-20-immunohistology revealed
no obvious differences in the musculature between het-
erozygous ext2 mutant and its wild type siblings (data
not shown). However, the craniofacial muscles in the
ext2−/− fish were shorter, broader and fitted the missha-
pen cartilaginous skeleton (Figure 3). Moreover, somered stain for ossification in the craniofacial skeleton at 6dpf. Dermal
hiostegal rays (br), opercle (op), cleithrum (cl), cartilage bones:
); and notochord (n), scale = 0.1 mm; B, The relative change in the
alysed by delta-delta-Ct in the homozygote ext2 mutants vs. wild type.
ssion was normalized against slc25a5. Error bars indicate means with
proximately 2-folds down-regulated and this under-expression was of
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position of muscles was observed around ext2−/− heart
(Figure 3, Table 2, Additional file 1).
Oil red O, a stain for neutral triglycerides, lipids and
some lipoproteins, highlighted blood vessels, heart, tec-
tum, guts, swim bladder and the remains of yolk in all
fish (Figure 4A). In the ext2−/− fish, the staining was in-
tense and abnormally high lipid accumulation was ob-
served. Especially, deposits in the vasculature were more
pronounced (Figure 4A). Staining at the position of
missing bones could be observed in some larvae. Signifi-
cantly stronger (P < 0.001) Oil red O stain in the ext2−/−
fish coincided with over two fold overexpression of
pparg (Figure 4). Other adipogenic markers such as cebp,
srebp1c and scd1 were expressed at levels similar to wild
type (Figure 4C). Despite intense staining, abnormalFigure 3 Homozygous ext2 mutant displays musco-skeletal
phenotype. Whole mount immunolocalisation at 4dpf using MF-20
antibody for muscles (green) and collagen II for cartilage (red) shows
thicker and shorter muscles fitting the malformed cartilaginous
skeleton in the ext2−/− fish. Muscles: intermandibularis anterior (ima),
intermandibularis posterior (imp), adductor mandibulae (am),
interhyoideus (ih), hyohyoideus (hh), levator arcus palatine (lap), adductor
hyoideus (ah), dilator operculi (do), sternohyoideus (sh) and adductor
operculi (ao). Note missing hh muscle and, marked with a star,
increased musculature around heart (H) in ext2-/-. Scale = 0.1 mm.accumulation of lipids and overexpression of pparg, TLC
analysis of lipid extracts did not reveal any changes in
the profiles from wild type and ext2−/− fish (data not
shown).
Zebrafish adipocytes start to form by 8dpf and only
upon feeding [29]. Interestingly, in the ext2−/− fish, the
mRNA in situ hybridization showed that fabp11a-ex-
pressing cells are present in unfed larvae already at 5dpf
(Figure 4D).
Bone-to-fat switch in proteoglycan mutants
Observing a disturbance in the differentiation of mesen-
chymal cell lineages, we wonder if this is specific to the
ext2 mutant, or to proteoglycan deficiencies in common.
Using a panel of mutants described in previous studies
[18,20], we found that the hi954 (uxs1) mutant lacking
various proteoglycans and with a mild bone phenotype
did not show any alteration in lipid deposition as judged
by Oil red O (Figure 4B). Significantly increased (P <
0.005) levels of lipids were detected in the knypek (kny,
gpc4−/−) mutant, which lacks only a portion of HS and
has a mild bone phenotype (Figure 4B and Additional
file 2) [18,20]. Interestingly, the pinscher (pic/slc35b2)
mutant, which fails to sulphate different molecules (in-
cluding HS) and has a stronger bone phenotype [17,18],
only showed a very small, but statistically significant in-
crease in lipid levels (P < 0.05).
Can PPARG inhibition rescue bone formation in the
ext2−/− homozygote mutant?
Several drugs are known to affect lipid metabolism and
influence the bone-to-fat balance. Although it is unlikely
to expect a strong effect on total lipid levels in the early
stages of zebrafish development where the majority of
lipids come from yolk, application of GW9662, the an-
tagonist of PPARG, was shown to enhance bone differ-
entiation in zebrafish larvae [30]. As expected, we found
that treatment with 15 μM GW9662 added at 60hpf did
not have any significant effect on lipid levels (Figure 5A)
but did enhance formation of cartilage and dermal bones
in wild type and in the ext2 heterozygous mutant
(Figure 5B). In the ext2−/− fish, with the same treatment,
enhanced GFP expression was noted in tg(osterix:gfp)
larvae (data not shown) with improved ossification of
the previously existing bones. Bones that normally do
not develop in ext2−/− mutants, responded only partially
to the treatment with rescue and stimulated ossification
being observed in only some of the dermal bones; the
ext2−/−-cartilage bones were not rescued by this treatment
(Figure 5B). Similar effects were seen upon ≥7.5 μM pur-
morphamine treatment, which should stimulate a fat-to-
bone switch by activating hedgehog signalling (Figure 5).
Furthermore, we tested involvement of other signaling
pathways (HS-dependent) which stimulate bone-to-fat
Table 2 Cranial muscles in zebrafish head
3dpf 4dpf 5dpf
Region Time Muscle: Wild type ext2 (−/−) Wild type ext2 (−/−) Wild type ext2 (−/−)
M 62 Intermandibularis anterior ima x x* x x x x
H 58 Interhyoideus ih x x x x x x
B 62 Tranversus ventralis tv x x x x x x
M 62 Intermandibularis posterior imp x x x x x x
H 58 Hyohyoideus hh x a x a x a
B 85 Rectus ventralis rv na na na na na na
B 85 Rectus communis rc na na na na na na
M 53 Adductor mandibulae am x x x x x x
M 62 Levator arcus palatini lap x x x x x x
M 62 Dilator operculi do x x x x x x
H 68 Adductor hyoideus ah x x x x x x
H 68 Adductor operculi ao x x* x x* x x*
B 72 Dorsal pharyngeal wall dpw na na na na na na
H 85 Levator operculi lo na na na na na na
E 62 Inferior oblique io na na na na na na
E 58 Inferior rectus ir na na na na na na
E 58 Lateral rectus lr na na na na na na
E 53 Medial rectus mr na na na na na na
B 53 Sternohyoideus sh x xx x xx x xx
E 58 Superior oblique so na na na na na na
E 58 Superior rectus sr na na na na na na
D 72 Protractor pectoralis pp a x* x x x x
Muscles were scored based on the MF-20 immuno staining of myosin (see Additional file 1) as described in [28] and indicated as: present (x), absent (a), or not
analysed (na). Asterisk indicate severely reduced muscles. Minimum seven fish were analysed in each group. B, Branchail arches; D, Dorsal posterior; E, Extraocular;
H, Hyoid arch; and M, Manibular arch. Time – number of hours post fertilization at which a muscle become visible.
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pathway) or dorsomorphine (an inhibitor of BMP) did
not show significant effect at any time point on the
craniofacial ext2−/− bones and TGF-β activator (TGF-
β3 ligand) only partially stimulated dermal bones (data
not shown).Is Ira1/Xbp1 pathway involved in the bone/lipid
phenotype of the ext2−/− fish?
Recently, Xbp1 was shown to regulate osteoblast dif-
ferentiation in a Runx2 independent manner [31].
Since in the ext2−/− fish the levels of runx2 tran-
script were normal while osterix levels were reduced,
we wondered if the unfolded protein response is
affected by the lack of HS. We found that heterozy-
gotes maintained WT-levels of ern1 and xpb1. In the
ext2−/− mutant, the expression of ern1 was only
slightly downregulated (2ΔΔCt ext2−/−/WT = 0,71),
but the expression of its downstream target, the
xbp1, was reduced to 0,64.Discussion
Abnormal lipid deposition coinciding with impaired
bone formation is not common to all types of proteogly-
can deficiencies (see Additional file 2). b3gat3- and
uxs1-homozygote mutants, that are upstream of ext2 in
the biosynthesis pathway and lack heparan and chondro-
itin sulphates, have a very mild bone phenotype and do
not show increased lipid deposition (this work and data
not shown). Interestingly, the fam20b and xylt1 mutants
downstream of uxs1 and upstream of b3gat3 and ext2
were shown to have enhanced bone ossification [32].
Unfortunately nothing is known about fam20b and xylt1
lipid metabolism. The ext2−/− and gpc4−/−, two mutants
with reduced HS-levels only, have high lipid content; but
only the ext2 mutants have severely reduced bone for-
mation, while the gpc4-null fish have very mild bone im-
pairment. The slc35b2 homozygote mutant, which has
diminished levels of all sulphated proteoglycans, has an
even more severe bone phenotype than the ext2−/− fish
and show only very mild enhancement of lipid depos-
ition. Why different proteoglycan deficiencies have such
Figure 4 Increased lipid levels in the ext2−/− fish coincide with decreased bone formation. A, Oil red O stain (ORO) in fish at 6dpf;
B, the levels of lipids represented as absorbance of bounded ORO in 6 days old proteoglycan mutants: ext2, slc35b2, gpc4 and uxs1 (for more
description see Additional file 2); C, the level of transcripts in 5-days old fish determined by quantitative PCR and normalised to slc25a5 level.
Primer sequences are given in Table 1; D, whole mount fabp11a mRNA in situ hybridisation showing prematurely developing adipocytes in
the belly of the ext2−/− fish. Error bars represent means with SEM.
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clear. Holmborn and coauthors [33] showed that, in the
ext2 homozygote mutant, the remaining HS are over-
sulphated which changes their properties (i.e. increase
occurrence of protein-interacting domains). Although,
heparin, a highly sulphated glycosaminoglycan and a po-
tent anticoagulant, which is often used in clinical practice,
negatively affects bone density and is known to increase
lipid deposition in sera, the role of over-sulphation of
(proteo-)glycans would need to be confirmed.
Craniofacial skeletal development in zebrafish is of
mixed origin being derived from cranial neural crest
and/or mesoderm [34]. The presence of one functional
copy of the ext2 gene is sufficient for the maintenance of
normal differentiation of chondrocytes, osteoblasts and
other mesenchyme-derived cells. Reduction in HS-levels
in the ext2−/− larvae clearly affects skeletal development.
Loss of bones cannot be linked specifically to one type
of precursor cell as both neural crest- and mesoderm-
derived structures are affected. Despite their origin, twopopulations of osteoblasts with different sensitivity to
hedgehog signalling have been described in zebrafish
[35]. As no defects in the hedgehog signalling were
found in the craniofacial skeleton of the ext2−/− fish, it is
unlikely that bone defects could be linked to a specific
type of hedgehog-sensitive osteoblast. However, it is pos-
sible that there are multiple types of osteoblasts existing
in fish, differing in their sensitivity for HS.
Bone homeostasis depends on the balance between
osteoblastic and osteoclastic activity. Lipids are known
to attract osteoclasts while suppressing osteoblastogene-
sis (for review see [36]). Unfortunately, we were not able
to test this in zebrafish as the first osteoclasts develop by
16 dpf, beyond the time of premature death of the ext2−/−
fish. Nevertheless, observations from patient material sug-
gest that indeed both osteoblasts and osteoclasts are af-
fected by HS-deficiencies [10,26] or by HS abnormal
accumulation [7] and, in both cases, bone mineral density
is altered. Osteoblasts and adipocytes might not be the
only lineages affected by imbalanced HS. EXT1-null
Figure 5 Bone and lipid phenotypes in the ext2−/− fish are
partially rescued by inhibition of PPAR or activation of
hedgehog signalling. A, Oil red O (ORO) stain for lipids in fish at
6dpf; B, Alizarin red stain for bones in fish at 6dpf. GW9662 (GW)
and purmorphamine (PM) were added into fish water by 60hpf and
fish were raised to 6dpf. Minimum 10 fish were scored from each
group and experiment was repeated with similar results at least
three times. Error bars represent means with SEM.
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entiation hematopoietic lineages [37], while osteochondro-
mas exhibit impaired vascularisation [38].
Fatty acids, when not stored in adipocytes, accumulate
into the circulation [39]. Although premature adipocyte-
like cells were detected in the ext2−/− fish it is unlikely
that they would be able to store all the lipids as cytoplas-
mic droplets. Therefore, Oil red O stain in vasculature
could reflect only a surplus of fatty acids/lipids. How-
ever, it is also possible that mutation in the ext2 gene
leads to an abnormal intravascular accumulation of
lipids. The changes in bones and fat that we have de-
scribed in fish were a characteristic of an organism
homozygous for a mutation in the ext2 gene in all cells.
Since MO patients are mostly heterozygous for a muta-
tion in EXT they should have very mild (if any) systemic
phenotype. However, if findings from this fish model are
true for humans, strong focal changes should be ex-
pected at the site where loss of heterozygosity/haplo-
insufficiency occured. Not much is known about lipid
metabolism in patients with MO. Lemos and co-authors
[10] reported lower bone mineral density of femoral
neck and lumbar spine in MO patients near osteochon-
dromas. In addition, single reports described deposition
of fat within the cartilaginous cap of osteochondromas
[11] and development of lipoma, a benign bone tumour,
or fat-pads in association with osteochondromas [40,41].
These finding might have been coincidental in MO but
increased lipid levels often remain asymptomatic. In
light of our findings in the fish model on the bone-fat
imbalance the status of lipids in human MO seems
worth investigating.
Humans, mice and fish with MO are often short in
stature and have bowed bones. Recently, Jones and co-
authors [42] demonstrated that osteochondroma grow-
ing on account of deranged bone growth is apparent
only in some individuals and other mechanisms must
contribute to the short bone phenotype. Also bone bow-
ing does not always require osteochondroma formation
to generate the observed anatomical changes (K. Jones,
University of Utah School of Medicine, personal com-
munication). The presence of muscle phenotype needs
to be confirmed in non-fish MO. Further work will show
how (if ) muscles with different mechanical properties
contribute to the formation of shorter and bowed bones
in patients.
Conclusions
Our data indicated that HS have multiple functions dur-
ing endochondral bone development. First of all, HS are
required for terminal differentiation of the cartilaginous
template and consecutive formation of a scaffold that is
needed for further bone development. Secondly, normal
expression of runx2 and impaired expression of osterix
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osteoblast precursors for their further differentiation
within the osteoblastic lineage. Furthermore, the in-
creased lipid deposition in the ext2−/− fish suggest that
HS are involved in determining the cell lineage when
mesenchymal precursor cell differentiates into bones
and/or fat. PCR analyses confirm the increase in the ex-
pression of lipid markers and down-regulation of early
skeletal markers. It still remains to be established how
HS are involved in this shift, but lower expression of
xbp1, a master regulator of osterix, suggests that HS
affect the unfolded protein response, a pathway which is
known to control bone formation and lipid metabolism.Supporting data
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